Correlation Between BB Biotech and Compagnie Financire

Can any of the company-specific risk be diversified away by investing in both BB Biotech and Compagnie Financire at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Compagnie Financire into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BB Biotech AG and Compagnie Financire Richemont, you can compare the effects of market volatilities on BB Biotech and Compagnie Financire and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Compagnie Financire. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Compagnie Financire.

Diversification Opportunities for BB Biotech and Compagnie Financire

-0.32

Correlation Coefficient

BB Biotech  Compagnie Financire

Very good diversification

The 3 months correlation between BION and Compagnie is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Compagnie Financire Richemont in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compagnie Financire and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Compagnie Financire. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compagnie Financire has no effect on the direction of BB Biotech i.e., BB Biotech and Compagnie Financire go up and down completely randomly.

Pair Corralation between BB Biotech and Compagnie Financire

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Compagnie Financire. But the stock apears to be less risky and, when comparing its historical volatility, BB Biotech AG is 1.57 times less risky than Compagnie Financire. The stock trades about -0.04 of its potential returns per unit of risk. The Compagnie Financire Richemont is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  11,706  in Compagnie Financire Richemont on September 17, 2024 and sell it today you would earn a total of  1,924  from holding Compagnie Financire Richemont or generate 16.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BB Biotech AG  vs.  Compagnie Financire Richemont

BB Biotech AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Compagnie Financire

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Compagnie Financire Richemont are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Compagnie Financire showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BB Biotech and Compagnie Financire

The main advantage of trading using opposite BB Biotech and Compagnie Financire positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Compagnie Financire can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compagnie Financire will offset losses from the drop in Compagnie Financire's long position.

The idea behind BB Biotech AG and Compagnie Financire Richemont pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.